We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT02013336
Brief Title: Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

First Submitted : December 11, 2013
First Submitted that Met QC Criteria : December 11, 2013
First Posted : December 17, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : March 17, 2022
Last Update Posted : March 31, 2022